Friederike Braulke

1.2k total citations
31 papers, 305 citations indexed

About

Friederike Braulke is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Friederike Braulke has authored 31 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Friederike Braulke's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Friederike Braulke is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Friederike Braulke collaborates with scholars based in Germany, Austria and United States. Friederike Braulke's co-authors include Detlef Haase, Julie Schanz, Katayoon Shirneshan, Gerald Wulf, Julia Hartmann, Frank Konietschke, Christina Ganster, Uwe Platzbecker, Lorenz Trümper and Michael Koziolek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Friederike Braulke

29 papers receiving 297 citations

Peers

Friederike Braulke
Anna Christoforidou Greece
Vittorio Fregoni Italy
Lidia Usnarska‐Zubkiewicz Poland
Yuliya Linhares United States
Fernando Vieira Pericole Brazil
Agnieszka Szymczyk Poland
Ana Isabel Teruel Spain
Ashwin Sridharan United States
Nazir Jamal Canada
H. L. Seewann Austria
Anna Christoforidou Greece
Friederike Braulke
Citations per year, relative to Friederike Braulke Friederike Braulke (= 1×) peers Anna Christoforidou

Countries citing papers authored by Friederike Braulke

Since Specialization
Citations

This map shows the geographic impact of Friederike Braulke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Braulke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Braulke more than expected).

Fields of papers citing papers by Friederike Braulke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friederike Braulke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Braulke. The network helps show where Friederike Braulke may publish in the future.

Co-authorship network of co-authors of Friederike Braulke

This figure shows the co-authorship network connecting the top 25 collaborators of Friederike Braulke. A scholar is included among the top collaborators of Friederike Braulke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friederike Braulke. Friederike Braulke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganster, Christina, Katayoon Shirneshan, Elżbieta Brzuszkiewicz, et al.. (2024). Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real‐world cohort of patients with lower‐risk MDS. HemaSphere. 8(9). e70014–e70014. 1 indexed citations
2.
Küffer, Stefan, Martin Leu, Alexander König, et al.. (2024). Effects of chemoradiotherapy on surface PD-L1 expression in esophageal cancer and its implications for immunotherapy. Frontiers in Immunology. 15. 1509051–1509051. 1 indexed citations
3.
4.
Klinkhammer‐Schalke, Monika, M. Meyer, Alexander Katalinic, et al.. (2024). Der einheitliche onkologische Basisdatensatz (oBDS). Forum. 39(3). 191–195. 1 indexed citations
5.
Buchholz, S, Christoph Ammer‐Herrmenau, Kirsten Reuter‐Jessen, et al.. (2023). Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology. Journal of Personalized Medicine. 13(12). 1701–1701. 2 indexed citations
6.
Braulke, Friederike, et al.. (2023). Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis. Journal of Cancer Research and Clinical Oncology. 149(16). 14775–14784. 3 indexed citations
7.
Evertz, Ruben, Miroslava Valentová, Tobias R. Overbeck, et al.. (2023). Predictors of lower exercise capacity in patients with cancer. Scientific Reports. 13(1). 14861–14861. 1 indexed citations
8.
Evertz, Ruben, Miroslava Valentová, Friederike Braulke, et al.. (2022). Cardiovascular and Metabolic Determinants of Quality of Life in Patients with Cancer. ESC Heart Failure. 10(1). 167–176. 4 indexed citations
9.
Braulke, Friederike, Julie Schanz, Katayoon Shirneshan, et al.. (2022). Cytogenetic peripheral blood monitoring in azacitidine treated patients with high-risk MDS/sAML: A monocentric real-world experience. Leukemia Research. 124. 106996–106996. 3 indexed citations
10.
Meyer, Hans‐Jonas, Wolfram Pönisch, Stefan Schmidt, et al.. (2019). Clinical and imaging features of myeloid sarcoma: a German multicenter study. BMC Cancer. 19(1). 1150–1150. 16 indexed citations
11.
Schanz, Julie, Christa Fonatsch, Friederike Braulke, et al.. (2018). Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders. Blood Cancer Journal. 8(3). 28–28. 16 indexed citations
12.
Ganster, Christina, Katayoon Shirneshan, Gabriela Salinas-Riester, et al.. (2015). Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS. Leukemia Research. 39(10). 1079–1087. 9 indexed citations
13.
Schanz, Julie, Friederike Braulke, & Detlef Haase. (2015). RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES. Mediterranean Journal of Hematology and Infectious Diseases. 7(1). e2015034–e2015034. 22 indexed citations
14.
Becher, Ulrich, Julie Schanz, Friederike Braulke, & Detlef Haase. (2015). RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES. Mediterranean Journal of Hematology and Infectious Diseases. 7(1). 2015–2015. 3 indexed citations
15.
16.
Hartmann, Julia, et al.. (2012). Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. Leukemia Research. 37(3). 327–332. 58 indexed citations
17.
Streit, Frank, Lutz Binder, Gunnar Brandhorst, et al.. (2011). Use of Total and Unbound Imatinib and Metabolite LC-MS/MS Assay to Understand Individual Responses in CML and GIST Patients. Therapeutic Drug Monitoring. 33(5). 632–643. 21 indexed citations
18.
Schroeder, Thomas, A. Kuendgen, Sabine Käyser, et al.. (2011). Therapy-related myeloid neoplasms following treatment with radioiodine. Haematologica. 97(2). 206–212. 25 indexed citations
19.
Braulke, Friederike, Julie Schanz, Klaus Jung, et al.. (2010). FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: Verification of the method and application to 27 MDS patients. Leukemia Research. 34(10). 1296–1301. 18 indexed citations
20.
Hartmann, Julia, Gerald Wulf, Lorenz Truemper, et al.. (2008). Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS. Blood. 112(11). 2694–2694. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Christoforidou Breakdown of academic impact, for papers by Vittorio Fregoni Breakdown of academic impact, for papers by Lidia Usnarska‐Zubkiewicz Breakdown of academic impact, for papers by Yuliya Linhares Breakdown of academic impact, for papers by Fernando Vieira Pericole Breakdown of academic impact, for papers by Agnieszka Szymczyk Breakdown of academic impact, for papers by Ana Isabel Teruel Breakdown of academic impact, for papers by Ashwin Sridharan Breakdown of academic impact, for papers by Nazir Jamal Breakdown of academic impact, for papers by H. L. Seewann
Rankless by CCL
2026